RBC Bioscience Overview
- Status
-
Public
- Employees
-
47
- Stock Symbol
-
6848
- Share Price
-
$0.61
- (As of Friday Closing)
RBC Bioscience General Information
Description
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.
Contact Information
Website
www.rbcbioscience.comCorporate Office
- 3F., No.132, Ln. 235, Baoqiao Road
- Xindian Dist
- New Taipei, 231-45
- Taiwan
Corporate Office
- 3F., No.132, Ln. 235, Baoqiao Road
- Xindian Dist
- New Taipei, 231-45
- Taiwan
RBC Bioscience Stock Performance
As of 20-Jun-2025, RBC Bioscience’s stock price is $0.61. Its current market cap is $7.89M with 13M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.61 | $0.60 | $0.48 - $0.76 | $7.89M | 13M | 15.9K | $0.05 |
RBC Bioscience Financials Summary
As of 31-Dec-2024, RBC Bioscience has a trailing 12-month revenue of $6.4M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 20,057 | 20,057 | 20,358 | 20,761 |
| Revenue | 6,396 | 6,396 | 5,537 | 5,841 |
| EBITDA | 1,709 | 1,709 | 1,179 | 1,077 |
| Net Income | 672 | 672 | 206 | 127 |
| Total Assets | 23,230 | 23,230 | 24,531 | 25,769 |
| Total Debt | 14,550 | 14,550 | 15,861 | 16,444 |
RBC Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RBC Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RBC Bioscience Patents
RBC Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160017314-A1 | Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples | Inactive | 06-Jun-2013 | ||
| US-20140364597-A1 | Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples | Inactive | 06-Jun-2013 | ||
| EP-2811022-A1 | Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples | Inactive | 06-Jun-2013 | ||
| DE-202013102057-U1 | Device for extracting nucleic acids by means of magnetic beads | Inactive | 10-May-2013 | ||
| EP-2805987-A1 | Method for manufacturing magnetic particle composite | Inactive | 18-Jan-2012 | C08J3/215 |
RBC Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RBC Bioscience FAQs
-
Where is RBC Bioscience headquartered?
RBC Bioscience is headquartered in New Taipei, Taiwan.
-
What is the size of RBC Bioscience?
RBC Bioscience has 47 total employees.
-
What industry is RBC Bioscience in?
RBC Bioscience’s primary industry is Discovery Tools (Healthcare).
-
Is RBC Bioscience a private or public company?
RBC Bioscience is a Public company.
-
What is RBC Bioscience’s stock symbol?
The ticker symbol for RBC Bioscience is 6848.
-
What is the current stock price of RBC Bioscience?
As of 20-Jun-2025 the stock price of RBC Bioscience is $0.61.
-
What is the current market cap of RBC Bioscience?
The current market capitalization of RBC Bioscience is $7.89M.
-
What is RBC Bioscience’s current revenue?
The trailing twelve month revenue for RBC Bioscience is $6.4M.
-
What is RBC Bioscience’s annual earnings per share (EPS)?
RBC Bioscience’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
